rs143008696

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_014339.7(IL17RA):​c.152C>T​(p.Thr51Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00367 in 1,613,292 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T51T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0023 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 10 hom. )

Consequence

IL17RA
NM_014339.7 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: -1.25

Publications

15 publications found
Variant links:
Genes affected
IL17RA (HGNC:5985): (interleukin 17 receptor A) Interleukin 17A (IL17A) is a proinflammatory cytokine secreted by activated T-lymphocytes. It is a potent inducer of the maturation of CD34-positive hematopoietic precursors into neutrophils. The transmembrane protein encoded by this gene (interleukin 17A receptor; IL17RA) is a ubiquitous type I membrane glycoprotein that binds with low affinity to interleukin 17A. Interleukin 17A and its receptor play a pathogenic role in many inflammatory and autoimmune diseases such as rheumatoid arthritis. Like other cytokine receptors, this receptor likely has a multimeric structure. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2014]
IL17RA Gene-Disease associations (from GenCC):
  • immunodeficiency 51
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • chronic mucocutaneous candidiasis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011457801).
BP6
Variant 22-17097075-C-T is Benign according to our data. Variant chr22-17097075-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 340565.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00225 (343/152226) while in subpopulation NFE AF = 0.00413 (281/68022). AF 95% confidence interval is 0.00373. There are 1 homozygotes in GnomAd4. There are 161 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL17RANM_014339.7 linkc.152C>T p.Thr51Met missense_variant Exon 2 of 13 ENST00000319363.11 NP_055154.3 Q96F46-1
IL17RANM_001289905.2 linkc.152C>T p.Thr51Met missense_variant Exon 2 of 12 NP_001276834.1 Q96F46-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL17RAENST00000319363.11 linkc.152C>T p.Thr51Met missense_variant Exon 2 of 13 1 NM_014339.7 ENSP00000320936.6 Q96F46-1

Frequencies

GnomAD3 genomes
AF:
0.00225
AC:
343
AN:
152108
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000749
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00413
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00178
AC:
447
AN:
251486
AF XY:
0.00161
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.00150
Gnomad ASJ exome
AF:
0.000794
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00314
Gnomad OTH exome
AF:
0.00309
GnomAD4 exome
AF:
0.00382
AC:
5580
AN:
1461066
Hom.:
10
Cov.:
30
AF XY:
0.00368
AC XY:
2678
AN XY:
726894
show subpopulations
African (AFR)
AF:
0.000359
AC:
12
AN:
33472
American (AMR)
AF:
0.00143
AC:
64
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000727
AC:
19
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86240
European-Finnish (FIN)
AF:
0.000468
AC:
25
AN:
53404
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.00462
AC:
5134
AN:
1111294
Other (OTH)
AF:
0.00534
AC:
322
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
249
497
746
994
1243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00225
AC:
343
AN:
152226
Hom.:
1
Cov.:
32
AF XY:
0.00216
AC XY:
161
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.000746
AC:
31
AN:
41528
American (AMR)
AF:
0.00163
AC:
25
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00413
AC:
281
AN:
68022
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
21
41
62
82
103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00324
Hom.:
4
Bravo
AF:
0.00242
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00698
AC:
60
ExAC
AF:
0.00174
AC:
211
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00425
EpiControl
AF:
0.00296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Immunodeficiency 51 Uncertain:1Benign:2
Mar 30, 2021
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

IL17RA NM_014339.6 exon 2 p.Thr51Met (c.152C>T):This variant has not been reported in the literature but is present in 0.3% (409/129168) of European alleles including 1 homozygote, in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/22-17577965-C-T?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:340565). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

IL17RA-related disorder Uncertain:1
Jun 28, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The IL17RA c.152C>T variant is predicted to result in the amino acid substitution p.Thr51Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.32% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including one homozygous individual. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
13
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
T;.
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.014
N
LIST_S2
Benign
0.78
T;T
M_CAP
Benign
0.0068
T
MetaRNN
Benign
0.011
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Uncertain
2.0
M;M
PhyloP100
-1.3
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.4
N;.
REVEL
Benign
0.099
Sift
Benign
0.10
T;.
Sift4G
Benign
0.18
T;T
Polyphen
1.0
D;.
Vest4
0.40
MVP
0.040
MPC
0.21
ClinPred
0.018
T
GERP RS
-6.8
Varity_R
0.053
gMVP
0.55
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143008696; hg19: chr22-17577965; COSMIC: COSV100083552; COSMIC: COSV100083552; API